{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "health-sciences:medicine:nephrology:neph-023",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:53:50.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "nephrology-specialist-agent"
    ],
    "confidence": 0.96,
    "status": "peer-reviewed",
    "modified": "2026-01-11T18:21:00.000Z",
    "quality_grade": "A"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/nephrology",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "high"
  },
  "skos": {
    "prefLabel": "Alport Syndrome",
    "altLabel": [
      "Hereditary Nephritis",
      "Hereditary Nephritis with Deafness",
      "COL4A-Associated Nephropathy"
    ],
    "definition": "A hereditary disorder of type IV collagen causing progressive nephropathy, sensorineural hearing loss, and ocular abnormalities, typically resulting from mutations in COL4A3, COL4A4, or COL4A5 genes.",
    "broader": [
      "health-sciences:medicine:nephrology:neph-022"
    ],
    "related": [
      "health-sciences:medicine:nephrology:thin-basement-membrane",
      "health-sciences:medicine:genetics:collagen-disorders",
      "health-sciences:medicine:ophthalmology:anterior-lenticonus"
    ],
    "scopeNote": "Classic triad of nephritis, sensorineural deafness, and ocular abnormalities; X-linked most common"
  },
  "medicalCode": {
    "SNOMED_CT": {
      "conceptId": "72934000",
      "term": "Alport syndrome"
    },
    "ICD_10": {
      "code": "Q87.81",
      "description": "Alport syndrome"
    },
    "ICD_11": {
      "code": "LD2F.2Y",
      "description": "Alport syndrome"
    },
    "MeSH": {
      "descriptorUI": "D009394",
      "descriptorName": "Nephritis, Hereditary"
    }
  },
  "content": {
    "title": "Alport Syndrome",
    "summary": "Alport syndrome is a hereditary nephropathy caused by mutations in type IV collagen genes (COL4A3, COL4A4, COL4A5), affecting the glomerular basement membrane, cochlea, and lens. It classically presents with microscopic hematuria progressing to proteinuria and ESKD, accompanied by sensorineural hearing loss and characteristic ocular findings.",
    "key_points": [
      "Caused by mutations in COL4A3, COL4A4, or COL4A5 (type IV collagen genes)",
      "X-linked dominant (COL4A5) is most common (80%); autosomal forms also exist",
      "Classic triad: nephritis, sensorineural hearing loss, ocular abnormalities",
      "Males with X-linked disease progress to ESKD by age 20-30",
      "Electron microscopy shows basket-weave appearance of GBM",
      "RAAS blockade slows progression but cannot prevent ESKD",
      "Anti-GBM disease can develop post-transplant (rare)"
    ],
    "statement": "Alport syndrome represents a spectrum of hereditary basement membrane disorders caused by mutations in type IV collagen. Understanding the inheritance patterns, clinical manifestations, and natural history is essential for diagnosis, family counseling, and management planning.",
    "explanation": {
      "intuition": "Think of type IV collagen as the 'rebar' that reinforces basement membranes throughout the body. In Alport syndrome, this collagen is defective, causing the glomerular basement membrane to become thin and fragile, eventually leading to scarring and kidney failure. The same collagen is found in the inner ear and eye, explaining the hearing and vision problems.",
      "key_insight": "The GBM normally undergoes a 'developmental switch' from α1α2α1 collagen IV (fetal) to α3α4α5 collagen IV (mature). In Alport syndrome, this switch cannot occur due to mutant collagen, leaving an immature GBM that is mechanically weak and progressively damaged by normal filtration pressures.",
      "technical_details": "Type IV collagen α3, α4, and α5 chains form a triple-helical network in the mature GBM, cochlear basement membrane, and lens capsule. Mutations in COL4A3/A4 (chromosome 2) cause autosomal forms; mutations in COL4A5 (X chromosome) cause X-linked disease. The defective GBM shows characteristic ultrastructural changes: thickening, thinning, lamellation, and basket-weave appearance on EM."
    },
    "definitions_glossary": {
      "type_IV_collagen": "Network-forming collagen specific to basement membranes; composed of six different alpha chains (α1-α6)",
      "glomerular_basement_membrane": "GBM - specialized basement membrane between podocytes and endothelium; primary filtration barrier",
      "COL4A5": "Gene encoding collagen IV α5 chain; located on X chromosome; mutations cause X-linked Alport",
      "COL4A3": "Gene encoding collagen IV α3 chain; mutations cause autosomal recessive or dominant Alport",
      "COL4A4": "Gene encoding collagen IV α4 chain; mutations cause autosomal recessive or dominant Alport",
      "basket_weave_appearance": "Characteristic EM finding in Alport syndrome showing irregular GBM with lamellation and splitting",
      "sensorineural_hearing_loss": "Hearing loss due to inner ear (cochlear) dysfunction; bilateral and progressive in Alport syndrome",
      "anterior_lenticonus": "Conical protrusion of the anterior lens surface; pathognomonic for Alport syndrome",
      "dot_and_fleck_retinopathy": "Retinal findings in Alport syndrome; yellowish-white dots in perimacular region",
      "thin_basement_membrane_disease": "Benign familial hematuria; may be heterozygous carrier state for autosomal Alport",
      "post_transplant_anti_GBM": "Alloimmune response to normal collagen IV in transplanted kidney; rare complication",
      "X_linked_dominant": "Inheritance pattern where affected males are more severely affected than heterozygous females",
      "developmental_switch": "Normal replacement of α1α2α1 collagen IV with α3α4α5 network during kidney maturation",
      "podocyte": "Specialized epithelial cell wrapping glomerular capillaries; contributes to filtration barrier"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Mutations in COL4A3, COL4A4, or COL4A5 prevent normal assembly of the α3α4α5 collagen IV network in the GBM. The persistence of immature α1α2α1 collagen leaves the GBM susceptible to mechanical stress, leading to progressive thinning, thickening, and lamellation. This causes hematuria, proteinuria, and eventually glomerulosclerosis.",
      "inheritance_patterns": {
        "X_linked": "80% of cases; COL4A5 mutations; males severely affected (ESKD by 20-30), females variable (carrier state to mild disease)",
        "autosomal_recessive": "15% of cases; homozygous or compound heterozygous COL4A3/A4 mutations; both sexes equally affected",
        "autosomal_dominant": "5% of cases; heterozygous COL4A3/A4 mutations; milder phenotype, later-onset ESKD"
      },
      "extrarenal_pathology": [
        "Cochlea: same collagen network in basilar membrane causes high-frequency hearing loss",
        "Eye: lens capsule and retina abnormalities from defective collagen IV"
      ]
    },
    "clinical_presentation": {
      "renal": [
        "Microscopic hematuria (earliest finding, often from childhood)",
        "Episodes of gross hematuria (triggered by URI)",
        "Progressive proteinuria",
        "Hypertension",
        "Chronic kidney disease progressing to ESKD"
      ],
      "hearing": [
        "Bilateral high-frequency sensorineural hearing loss",
        "Progressive; may require hearing aids",
        "Typically develops in late childhood/adolescence",
        "Present in 80% of X-linked males, variable in females"
      ],
      "ocular": [
        "Anterior lenticonus (pathognomonic) - 25% of X-linked males",
        "Dot-and-fleck retinopathy",
        "Posterior polymorphous corneal dystrophy",
        "Usually does not affect vision significantly"
      ]
    },
    "diagnostic_criteria": {
      "clinical_criteria": [
        "Family history of hematuria ± renal failure",
        "Sensorineural hearing loss",
        "Characteristic ocular findings (anterior lenticonus)",
        "GBM abnormalities on electron microscopy"
      ],
      "genetic_testing": {
        "recommended": true,
        "genes": ["COL4A3", "COL4A4", "COL4A5"],
        "advantages": "Non-invasive, can identify carriers, enables genetic counseling"
      },
      "renal_biopsy": {
        "light_microscopy": "Often nonspecific; may show FSGS pattern late",
        "immunofluorescence": "Absent α3, α4, α5 collagen IV staining (X-linked males); mosaic pattern in carrier females",
        "electron_microscopy": "Diagnostic: GBM thinning/thickening, lamellation, basket-weave appearance"
      },
      "audiometry": "High-frequency sensorineural hearing loss",
      "ophthalmology": "Slit-lamp exam for anterior lenticonus"
    },
    "treatment_options": {
      "renoprotection": [
        "ACE inhibitors or ARBs - first-line; shown to delay ESKD by 5-10 years",
        "Start at diagnosis of proteinuria, even in children",
        "Blood pressure control",
        "SGLT2 inhibitors - emerging evidence for benefit"
      ],
      "monitoring": [
        "Regular urinalysis and quantitative proteinuria",
        "Serial renal function testing",
        "Audiometry every 1-2 years",
        "Ophthalmologic exam"
      ],
      "renal_replacement_therapy": [
        "Dialysis when indicated",
        "Kidney transplantation is treatment of choice for ESKD",
        "3-5% risk of post-transplant anti-GBM disease (Alport post-transplant nephritis)"
      ],
      "genetic_counseling": [
        "Essential for family planning",
        "Identify at-risk family members",
        "Prenatal/preimplantation genetic testing available"
      ]
    },
    "prognosis": {
      "X_linked_males": "ESKD by age 20-30 in most; hearing loss in 80%",
      "X_linked_females": "Variable; 15-30% reach ESKD by age 60",
      "autosomal_recessive": "ESKD by age 20-30, similar to X-linked males",
      "autosomal_dominant": "Later onset; ESKD in 50% by age 60"
    }
  },
  "pedagogical": {
    "learning_objectives": [
      "Describe the genetic basis and inheritance patterns of Alport syndrome",
      "Recognize the classic clinical triad of nephritis, hearing loss, and ocular abnormalities",
      "Interpret renal biopsy findings, particularly electron microscopy features",
      "Differentiate Alport syndrome from thin basement membrane disease",
      "Outline management strategies to slow progression to ESKD",
      "Explain the risk of post-transplant anti-GBM disease"
    ],
    "clinical_pearls": [
      "Family history of hematuria with hearing loss = think Alport syndrome",
      "Anterior lenticonus is pathognomonic - always do ophthalmologic exam",
      "Thin basement membrane disease may be a carrier state for autosomal Alport",
      "Start ACE inhibitors early - proven to delay ESKD by years",
      "Genetic testing is now preferred over skin/kidney biopsy for diagnosis",
      "Warn transplant team about post-transplant anti-GBM risk (rare but serious)"
    ],
    "board_yield": {
      "high_yield_topics": [
        "COL4A5 mutation and X-linked inheritance",
        "Classic triad (nephritis, deafness, ocular)",
        "Basket-weave GBM on electron microscopy",
        "Anterior lenticonus"
      ],
      "common_question_stems": [
        "Young male with hematuria, proteinuria, and hearing loss",
        "Electron microscopy showing basket-weave GBM",
        "Family pedigree showing X-linked inheritance pattern with nephritis",
        "Patient with Alport syndrome receiving kidney transplant"
      ],
      "exam_tips": [
        "Alport = COL4A mutations + nephritis + hearing loss + eye findings",
        "X-linked = males affected severely, females variably",
        "Basket-weave on EM is diagnostic"
      ]
    },
    "teaching_cases": [
      {
        "scenario": "14-year-old boy with persistent microscopic hematuria since age 5, now developing proteinuria. Mother has isolated hematuria. Maternal uncle on dialysis at age 28.",
        "key_findings": "High-frequency hearing loss on audiometry, anterior lenticonus on slit-lamp. EM shows basket-weave GBM.",
        "diagnosis": "X-linked Alport syndrome (COL4A5 mutation)",
        "management": "Start ACE inhibitor, regular monitoring, genetic counseling for family"
      }
    ]
  },
  "prerequisites": [
    "health-sciences:medicine:nephrology:neph-011",
    "health-sciences:medicine:genetics:inheritance-patterns",
    "health-sciences:medicine:anatomy:glomerular-structure"
  ],
  "related_concepts": [
    "health-sciences:medicine:nephrology:thin-basement-membrane",
    "health-sciences:medicine:genetics:collagen-disorders",
    "health-sciences:medicine:nephrology:neph-048",
    "health-sciences:medicine:otolaryngology:sensorineural-hearing-loss"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "Kashtan CE, Ding J, Garber M, et al.",
        "title": "Alport syndrome: a unified classification of genetic disorders of collagen IV",
        "journal": "Journal of the American Society of Nephrology",
        "year": 2018,
        "doi": "10.1681/ASN.2017080911",
        "pmid": "29521663"
      },
      {
        "authors": "Savige J, Gregory M, Gross O, et al.",
        "title": "Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy",
        "journal": "Journal of the American Society of Nephrology",
        "year": 2013,
        "doi": "10.1681/ASN.2012020148",
        "pmid": "23334396"
      }
    ],
    "confidence_rationale": "Based on established genetics literature and expert consensus guidelines"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-11T18:21:00.000Z",
    "sources": [
      {
        "source": "Alport Syndrome Foundation Guidelines",
        "type": "clinical-guideline",
        "year": 2018,
        "url": "https://www.alportsyndrome.org/",
        "relevance": "Expert consensus on diagnosis and management"
      },
      {
        "source": "GeneReviews - Alport Syndrome",
        "type": "reference",
        "year": 2021,
        "url": "https://www.ncbi.nlm.nih.gov/books/NBK1207/",
        "relevance": "Comprehensive genetic review"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.94,
    "clinical_accuracy": 0.96,
    "pedagogical_effectiveness": 0.92,
    "completeness": 0.95,
    "last_review": "2026-01-11T18:21:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Alport_syndrome",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q381993"
}